Tesamorelin
| 매개변수 | 사양 |
|---|---|
| 제품명 | Tesamorelin |
| CAS 번호 | 218949-48-5 |
| 분자식 | C221H366N72O67S |
| 분자량 | 5135.8 g/mol |
| 외관 | White to off-white lyophilized powder |
| 분석법 (HPLC) | ≥98.0% |
| 용해도 | Soluble in water and aqueous buffers |
| 패키지 | 1 g, 5 g, 10 g, 50 g, 100 g |
도움이 필요하신가요? 저희 팀에 문의해 주세요
동의어: Tesamorelin, Tesamorelin acetate, TH9507, Egrifta, N-[(3-Methylbutanoyl)oxy]… (full IUPAC name), Tesamorelin trifluoroacetate
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) used in pharmaceutical and research settings. It is produced via solid-phase peptide synthesis and supplied as a sterile-filtered lyophilized powder. The product is available in research-grade and GMP-grade qualities, with the GMP grade intended for clinical trial and commercial manufacturing.
Our Tesamorelin is characterized by high purity and consistent batch-to-batch reproducibility. Each lot is tested for identity, purity, and peptide content. The material is shipped with a certificate of analysis (COA) and a material safety data sheet (MSDS). For bulk orders, a technical data sheet (TDS) is available upon request.
We supply Tesamorelin in two grades: research-grade (≥95% purity) and GMP-grade (≥98% purity). Both are lyophilized powders. The GMP grade is manufactured under current good manufacturing practices and is suitable for use in clinical trials and commercial production. Custom packaging and labeling are available for bulk orders.
Tesamorelin is primarily used in the formulation of injectable solutions for the treatment of HIV-associated lipodystrophy. It is also employed in research settings to study growth hormone regulation. Formulators typically dissolve the lyophilized powder in bacteriostatic water or saline to prepare injectable solutions. The compound is compatible with common excipients used in peptide formulations.
send us your specification for a quotation.
English English 
Russian
French
Korean
German
Polish
Japanese
Spanish
Italian
Vietnamese